Korean J Pediatr Hematol Oncol.  2003 Apr;10(1):58-63.

Neopterin as a Marker of Disease Activity in Childhood Acute Lymphocytic Leukemia

Affiliations
  • 1Department of Pediatrics, Yonsei University College of Medicine, Seoul, Korea. chyang@navekids.co.kr

Abstract

PURPOSE
Neopterin is a degradation product derived from guanosin triphosphate (GTP) during biosynthesis of tetrahydrobiopterin. It is produced by human monocytes/macrophages upon stimulation with interferon-gamma from activated T lymphocytes. Therefore, increased neopterin concentration suggests the activation of cell-mediated immune response during viral infections, autoimmune diseases, allograft rejection, immunodeficiencies and certain types of malignancy. In these diseases, increased neopterin concentrations in serum and urine correlate to the stage of disease and predict worse prognosis. It has been proved that in various malignant disorders, higher neopterin concentrations are associated with more rapid disease progression and are a valuable predictor of stage and extension of the tumor. METHODS: Serum neopterin concentrations were measured by ELISA test in 20 patients with acute lymphocytic leukemia (ALL) at diagnosis and at complete remission after induction chemotherapy, and in 20 normal children that served as the control group. RESULTS: Serum neopterin levels were significantly (P=0.021) increased in the ALL group at diagnosis (9.48 nmol/L) compared to the control group (4.49 nmol/L). In the ALL group, serum neopterin levels were significantly (P=0.015) decreased at complete remission state (6.84 nmol/L) compared to the time of diagnosis (11.96 nmol/L). CONCLUSION: Neopterin was shown to be a valuable indicator of disease activity in childhood ALL and will contribute to predicting the treatment response.

Keyword

Neopterin; Acute lymphocytic leukemia

MeSH Terms

Allografts
Autoimmune Diseases
Child
Diagnosis
Disease Progression
Enzyme-Linked Immunosorbent Assay
Humans
Induction Chemotherapy
Interferon-gamma
Neopterin*
Precursor Cell Lymphoblastic Leukemia-Lymphoma*
Prognosis
T-Lymphocytes
Interferon-gamma
Neopterin
Full Text Links
  • KJPHO
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr